The Future of TAVR: 3-Year SMART Trial Results

  • Published:  18 June 2026
  • Likes: 

    Heart Icon

    1

Up Next
  • episode_image
    2m 45s
    Part 2 | Session 1 Welcome & Introduction
    Howard C Herrmann, Zarina Sharalaya, Matthew Summers, Kelly C. Epps Anderson, Craig Basman , Leonardo Guimarães, Alejandro Alcocer, Pablo Lamelas, Walid Ben Ali
  • episode_image
    2m 28s
    Part 1 | Session 1 Welcome & Introduction
    Howard C Herrmann, Leonardo Guimarães, Pablo Lamelas, Walid Ben Ali, Alejandro Alcocer

The Future of TAVR: 3-Year SMART Trial Results

  • Published:  18 June 2026
  • Likes: 

    Heart Icon

    1

Average (ratings)
No ratings
Your rating
Overview

The Future of TAVR: 3-Year SMART Trial Results webinar series explores the key outcomes of the SMART Trial and what they reveal about improving care for patients undergoing transcatheter valve intervention.

The series focuses on how trial findings inform everyday clinical decisions, with particular attention to bioprosthetic valve dysfunction, prosthesis–patient mismatch and thrombosis. Special consideration is given to small annuli patients, including those with an annular area below 430 mm², and to women, where anatomy and haemodynamics can significantly influence outcomes. The discussion connects evidence to practice, highlighting how structured pre-procedural planning, imaging and patient selection can optimise results.

This video series is supported by

Key Learning Objectives

  • Outline definitions and types of BVD, preventative strategies, and implications.
  • Translate trial results into real-world clinical practice.
  • Understand how pre-case planning, imaging, and tools can support patient selection.
  • Identify indicators of low-flow, low-gradient severe aortic stenosis.

Target Audience

  • Interventional Cardiologists
  • Structural Heart Intervention Specialist
  • Cardiac Imaging Specialists
  • Cardiothoracic surgeon

More from this programme

Faculty Biographies

Howard C Herrmann

Howard C Herrmann

Director, Cardiac Catheterization Laboratories

Howard C Herrmann, MD, is a Professor of Medicine at the University of Pennsylvania School of Medicine and Director of Interventional Cardiology and the Cardiac Catheterization Laboratories at the Hospital of the University of Pennsylvania, Philadelphia. He has authored or co-authored more than 200 articles on numerous topics in interventional cardiology. His research focuses on the clinical investigation of new therapies for valvular and structural heart disease. He is Past President of the Pennsylvania Chapter of the American College of Cardiology (ACC) and serves on numerous national committees and Editorial Boards. Dr Herrmann earned his AB at Harvard College and his MD at Harvard Medical School, and completed his training at Massachusetts General Hospital.

View full profile
Leonardo de Freitas Campos Guimarães

Leonardo de Freitas Campos Guimarães

Interventional Cardiologist

Dr Leonardo de Freitas Campos Guimarães is an interventional cardiologist with advanced training in structural heart disease. He completed his medical degree and residencies in Internal Medicine, Cardiology, and Interventional Cardiology at UNIFESP (São Paulo, Brazil), where he also obtained a PhD in Cardiology. He further specialized through a Structural Heart Disease fellowship at the Institut Universitaire de Cardiologie et de Pneumologie de Québec (Université Laval, Canada). 

Dr Guimarães currently practices as an interventional cardiologist at leading institutions in Brazil, including HCor and Hospital Santa Catarina, with extensive experience in TAVR, valve‑in‑valve procedures, and complex structural interventions. Since FY25, he has participated as a proctor in 149 proctoring cases in Brazil, demonstrating a high level of procedural expertise and leadership in physician training. In addition, Dr Guimarães has actively participated as a speaker in multiple…

View full profile
 Alejandro  Alcocer

Alejandro Alcocer

Associate Professor of Interventional Cardiology

Dr Alejandro Alcocer is Associate Professor of Interventional Cardiology at Hospital Regional 1° de Octubre, ISSSTE, Mexico City, México. He is the current President of ANCISSSTE (the ISSSTE National Cardiologists Association), the leading professional body representing cardiologists within the ISSSTE health system across Mexico. With over 20 years of experience in interventional cardiology, Dr Alcocer has built a distinguished career dedicated to advancing cardiac care in Mexico and Latin America.

View full profile
Pablo Lamelas

Pablo Lamelas

Interventional Cardiologist

Interventional Cardiologist, Instituto Cardiovascular de Buenos Aires (ICBA)
His areas of interest have centered around Coronary, complex angioplasty, chronic total occlusion angioplasty and structural heart disease interventions.

View full profile
Walid Ben Ali

Walid Ben Ali

Cardiac Surgeon & Structural Heart Specialist

Dr Walid Ben Ali, MD, PhD, FRCSC is a cardiac surgeon, researcher, and medical innovator at the Montreal Heart Institute (Institut de Cardiologie de Montréal) and Assistant Clinical Professor at the Université de Montréal Faculty of Medicine. Dr Ben Ali specializes in minimally invasive and percutaneous cardiac interventions, including transcatheter aortic valve replacement (TAVR/TAVI), robotic-assisted surgeries, and complex mitral and tricuspid valve repairs. He played a key role in expanding MHI's surgical capacity, contributing to a North American record where surgical teams performed mitral and tricuspid procedures on 23 patients within a single operating room in one week.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.